We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Ring with Lab-on-a-Chip Technology Rapidly Diagnoses STDs in a Single Blood Test

By LabMedica International staff writers
Posted on 07 Sep 2015
A low-cost, point-of-care and personal diagnostics thumb-ring has been successfully developed to test for sexually transmitted diseases (STDs) such as syphilis, gonorrhea, chlamydia, and trichomoniasis, transmitting data to a smartphone where an app quickly presents the results.

The innovative “Hoope” ring was designed by mechanical engineer Ernesto Rodriguez Leal, PhD, from Monterrey (Mexico). More...
"Every year more than 500 million people around the world contract one of these four STDs, 50% are between 15 to 23 years of age. The problem is that 75% do not present early symptoms, therefore the need for an early-detection strategy," he said.

Hoope is placed on the thumb and contains a disposable cartridge with a retractable single-use needle. It also contains an anesthetic system by which an electrical pulse generates numbness, preventing pain at the time of puncture. It is worn only at the time of testing and functions as a personal diagnostic tool. A button is pressed, activating the needle to draw blood, which is transported by capillary action and taken into a lab-on-a-chip, where the blood is distributed into 4 microfluidic channels. "We put antigens specifically synthesized to catch antibodies for each of the diseases,” said Dr. Rodreges Leal, “If antibodies for any of the conditions exists, the antigens trap them and produce an electrochemical reaction."

Data are wirelessly transmitted to a device such as a smartphone or tablet, where an app shows the results in less than a minute. In cases of positive results, the app provides related medical information and a map showing the location of the nearest specialist with whom an appointment can be scheduled.

The Hoope portable device project was developed at a Mexican startup in Silicon Valley. "There I met Damel Mektepbayeva, biotechnologist from Kazakhstan, and Irina Rymshina, Russian finance expert, the three of us decided to create Hoope," explained Dr. Rodríguez Leal. He arrived to Silicon Valley through the Singularity University program consisting of a 3-month stay at NASA that brings together 80 people from around the world. "In this program I learned the tools needed to conceptualize social impact projects and transform the idea from the lab to an end product," he said, "The first prototype was designed at the Colorado State University located in Fort Collins, it showed excellent results in the detection of syphilis, and we are working to perfect it for the other three diseases."

With this technological development the researchers have won several international competitions. The device will be manufactured in China and made available January 2016 through an Indiegogo campaign. A specialized app will also be released. Hoope will initially be marketed in Latin America (later in Europe and the United States) at a price of approximately USD 50 for the ring and three cartridges. Currently the team continues to improve the device, including for its potential to be adapted to detect allergies, cancer, diabetes, and pregnancy.

Related Links:

Hoope
Singularity University 



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Amoebiasis Test
ELI.H.A Amoeba
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.